- Home
- FBP vs IMVT Comparison
FBP vs IMVT Comparison
Compare FBP & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBP
- IMVT
- Stock Information
- Founded
- FBP 1948
- IMVT N/A
- Country
- FBP United States
- IMVT United States
- Employees
- FBP N/A
- IMVT N/A
- Industry
- FBP Major Banks
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBP Finance
- IMVT Health Care
- Exchange
- FBP Nasdaq
- IMVT Nasdaq
- Market Cap
- FBP 2.9B
- IMVT 2.5B
- IPO Year
- FBP N/A
- IMVT N/A
- Fundamental
- Price
- FBP $20.07
- IMVT $14.14
- Analyst Decision
- FBP Buy
- IMVT Buy
- Analyst Count
- FBP 4
- IMVT 10
- Target Price
- FBP $22.50
- IMVT $40.14
- AVG Volume (30 Days)
- FBP 1.2M
- IMVT 1.4M
- Earning Date
- FBP 04-24-2025
- IMVT 05-28-2025
- Dividend Yield
- FBP 3.57%
- IMVT N/A
- EPS Growth
- FBP 4.49
- IMVT N/A
- EPS
- FBP 1.84
- IMVT N/A
- Revenue
- FBP $884,832,000.00
- IMVT N/A
- Revenue This Year
- FBP $5.93
- IMVT $108.88
- Revenue Next Year
- FBP $6.63
- IMVT N/A
- P/E Ratio
- FBP $10.95
- IMVT N/A
- Revenue Growth
- FBP 2.45
- IMVT N/A
- 52 Week Low
- FBP $16.40
- IMVT $12.72
- 52 Week High
- FBP $22.40
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- FBP 60.20
- IMVT 42.87
- Support Level
- FBP $19.89
- IMVT $13.36
- Resistance Level
- FBP $20.59
- IMVT $14.76
- Average True Range (ATR)
- FBP 0.47
- IMVT 0.89
- MACD
- FBP 0.10
- IMVT 0.05
- Stochastic Oscillator
- FBP 78.15
- IMVT 36.36
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).